Gilbert's disease and atazanavir: From p
β
Tim O. Lankisch; Ulrike Moebius; Michael Wehmeier; Georg Behrens; Michael P. Man
π
Article
π
2006
π
John Wiley and Sons
π
English
β 256 KB
Gilbert's disease leads to intermittent non-hemolytic hyperbilirubinemia by a reduction of hepatic bilirubin glucuronidation associated with the presence of the UDP-glucuronosyltransferase (UGT) 1A1\*28 polymorphism. It is considered benign because it does not result in hepatocellular damage. Howeve